Newer posts are loading.
You are at the newest post.
Click here to check if anything new just came in.

Ebola vaccine trial suspended in Geneva

Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates as a precautionary measure after some volunteers reported unexpected side effects. In a statement issued on Thursday, Geneva University Hospital said the trial had been suspended. The study, so far involving 59 people, began in November. Researchers reported four cases of mild joint pain in the hands and feet of people who received the shot ten to 15 days earlier. Officials will stop giving the vaccine next week in order to get more data and liaise with others who are testing the vaccine in the United States, Canada, Germany and Gabon. The vaccine was developed by Canada’s public health agency and is licensed to two US companies, NewLink and Merck. The trial is scheduled to resume in January in Geneva. The Swiss Agency for Therapeutic Products, Swissmedic, approved a second vaccine for testing. The second vaccine is produced by GlaxoSmithKline (GSK) and the US National ... Show more

Don't be the product, buy the product!

Schweinderl